{
"procedureNumber": "EMEA/H/C/001109/II/0043",
"productName": "Ilaris",
"productNumber": "1009",
"procedureType": "TYPE_II",
"activeSubstance": "canakinumab",
"additionalMonitoring": false,
"article58": false,
"atc": "L04AC08",
"biosimilar": true,
"conditionalApproval": false,
"exceptionalCircumstances": false,
"generic": true,
"legalAction": false,
"mah": "Novartis Europharm",
"orphan": false,
"paediatric": true,
"productStatus": "INVALID",
"smallMediumEnterprise": false,
"plannedChmpOpinionDate": "2016-08-08T00:00:00",
"procedureStartDate": "2016-08-01T00:00:00"}
